This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurology  • Neuro-otology  • Hearing Loss/ Deafness  • Alert me on articles by topic  Social Bookmarking   What's this?

Leif Nordang, MD; Claude Laurent, PhD; Tom Erik Mollnes, PhD

Arch Otolaryngol Head Neck Surg. 1998;124:633-636.

Objective  To test whether complement activation is associated with sudden deafness.

Design  Plasma samples obtained from patients in the acute phase of sudden deafness were analyzed for complement activation measured by C3bc levels and terminal complement complex. Comparisons were made with plasma samples from healthy controls.

Patients  Twenty-five adult patients with unilateral sudden deafness. The criteria for inclusion were symptoms of hearing loss for not longer than 14 days and a hearing loss of 35 dB or more measured at entry.

Results  Levels of C3bc were higher in patients compared with controls (P<.001). There were no differences in the formation of terminal complement complex in patients and controls.

Conclusions  The elevated levels of C3bc in patients with sudden deafness indicate an activation of the first part of the complement cascade and therefore suspected inflammatory causes. Measurements of C3bc levels might identify patients with sudden deafness who would benefit from treatment with anti-inflammatory drugs.

From the Departments of Oto-Rhino-Laryngology, University of Uppsala, Uppsala (Dr Nordang) and University of Umeå, Umeå (Dr Laurent), Sweden; and the Department of Immunology and Transfusion Medicine, Nordland Central Hospital, Bodø, and University of Tromsø, Tromsø, Norway (Dr Mollnes).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?